Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.
Published by
European journal of heart failure
Summary
journal-article
Head of Research and Development
Germany
→
Published by
European journal of heart failure
Summary
journal-article
Published by
JACC. Basic to translational science
Summary
journal-article
Published by
Molecular therapy : the journal of the American Society of Gene Therapy
Summary
journal-article
Published by
Circulation. Heart failure
Summary
journal-article
Published by
Journal of the American College of Cardiology
Summary
journal-article
Published by
European heart journal
Summary
journal-article
Published by
European heart journal
Summary
journal-article
Published by
European heart journal
Summary
journal-article
Published by
Journal of molecular and cellular cardiology
Summary
journal-article
Published by
Nature communications
Summary
journal-article
Published by
International journal of molecular sciences
Summary
journal-article
Published by
FEBS letters
Summary
journal-article
Published by
Circulation research
Summary
journal-article
Published by
Circulation research
Summary
journal-article
Published by
Circulation research
Summary
journal-article
Published by
Physiological reviews
Summary
journal-article
Published by
Science translational medicine
Summary
journal-article
Published by
Circulation
Summary
journal-article
Published by
Journal of molecular and cellular cardiology
Summary
journal-article
Published by
Experimental lung research
Summary
journal-article
Published by
Cardiovascular research
Summary
journal-article
Published by
American journal of physiology. Heart and circulatory physiology
Summary
journal-article